Syquant Capital SAS’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Syquant Capital SAS’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-406,686	Closed	-$16M	–	18
2023 Q2	$16M	Buy	+406,686	New	+$14.4M	11.62%	2

Syquant Capital SAS's ISEE Position: Q3 2023 in Review

Syquant Capital SAS sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 406,686 shares — an estimated $16M sold.

Syquant Capital SAS first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $16M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Syquant Capital SAS reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Syquant Capital SAS sold 406,686 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $16M.
Syquant Capital SAS first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Syquant Capital SAS's IVERIC bio, Inc. Common Stock position peaked at $16M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Syquant Capital SAS's 13F filing for Q3 2023, filed 12 Oct 2023.